These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 23335312
1. Two cases of subfoveal choroidal neovascularization with tubulointerstitial nephritis and uveitis syndrome. Takemoto Y, Namba K, Mizuuchi K, Ohno S, Ishida S. Eur J Ophthalmol; 2013; 23(2):255-7. PubMed ID: 23335312 [Abstract] [Full Text] [Related]
9. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration. Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A. Retina; 2007 Jun; 27(4):432-8. PubMed ID: 17420694 [Abstract] [Full Text] [Related]
11. Bevacizumab for choroidal neovascularization related to inflammatory diseases. Kramer M, Axer-Siegel R, Jaouni T, Reich E, Hemo I, Priel E, Averbukh E, Ehrlich R, Chowers I, Weinberger D, Amer R. Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273 [Abstract] [Full Text] [Related]
14. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial. Zhang H, Liu ZL, Sun P, Gu F. Am J Ophthalmol; 2012 Feb; 153(2):300-306.e1. PubMed ID: 21982109 [Abstract] [Full Text] [Related]
15. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Ach T, Hoeh AE, Ruppenstein M, Kretz FT, Dithmar S. Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764 [Abstract] [Full Text] [Related]
16. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child. Chhablani J, Jalali S. Eur J Ophthalmol; 2012 Oct; 22(4):677-9. PubMed ID: 22139615 [Abstract] [Full Text] [Related]
17. Three cases of tubulointerstitial nephritis and uveitis syndrome with different clinical manifestations. Nagashima T, Ishihara M, Shibuya E, Nakamura S, Mizuki N. Int Ophthalmol; 2017 Jun; 37(3):753-759. PubMed ID: 27511057 [Abstract] [Full Text] [Related]
18. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C. J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [Abstract] [Full Text] [Related]
19. Treatment of choroidal neovascularization using intravitreal bevacizumab. Pedersen R, Soliman W, Lund-Andersen H, Larsen M. Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757 [Abstract] [Full Text] [Related]
20. Subfoveal choroidal thickness in idiopathic choroidal neovascularization and treatment outcomes after intravitreal bevacizumab therapy. Kim H, Lee K, Lee CS, Byeon SH, Lee SC. Retina; 2015 Mar; 35(3):481-6. PubMed ID: 25313710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]